Mamoclam, 40 pcs.

Mamoclam® has a therapeutic effect in cystic fibrosis mastopathy.

It reduces manifestations of mastalgia, leads to regression of cysts, normalizes the processes of proliferation of mammary gland epithelium.

Indications

Breast pain

Cystic fibrosis mastopathy.

Active ingredient

Kelp Layers

Composition

Active substances:

Clam substance (in terms of dry substance) not less than 0.1 g; lipids not less than 0.04 g; iodine (in organically bound form) not less than 0.1 mg;

Supplementary substances:

MCC;

Milk sugar;

refined sugar;

potato starch;

PVP low molecular weight medical;

magnesium carbonate;

calcium stearate;

methylcellulose;

Titanium dioxide pigment grade A;

Tween 80;

Copper chlorophyll derivatives.

How to take, the dosage

Internal, before meals, single dose – 1-2 tablets 2-3 times a day at regular intervals during the day (daily dose – 3-6 tablets), the duration of treatment – not more than 1 month.

If necessary, it is recommended to repeat the course of treatment after a break of 2 weeks to 3 months.

Interaction

When using the drug Mamoklam ® body receives iodine in doses somewhat higher than the recommended physiological norm of the microelement, in this regard Mamoklam ® should not be used with drugs that contain iodine.

Contraindications

• Hypersensitivity to the ingredients of the drug;

• Kidney disease;

• hyperfunction of the thyroid gland;

• multinodular goiter;

• thyrotoxicosis of various genesis;

• furunculosis,

  <

• chronic pyoderma

• hemorrhagic diathesis

Side effects

Allergic reactions, mainly in the form of skin itching, redness of the skin and skin rashes, heartburn, flatulence, diarrhea.

Overdose

Overdose phenomena when using Mamoclama® have not been revealed.

Pregnancy use

During pregnancy and lactation is possible to use iodine only in physiological doses of no more than 250 mg per day.

Similarities

Laminaria sediments (seaweed)